Daftar Login

MBS-303(MBS-303) - CD20 x CD3_

MEREK : mbs303

MBS-303(MBS-303) - CD20 x CD3_

mbs303MBS 303 is a bispecific antibody targeting CD3CD20 being developed by Beijing Mabworks Biotech for the treatment of B cell non-Hodgkin lymphoma. TheMBS-303: CD20CD3Beijing Mabworks Biotech Co., Ltd. ()12

IDR 10.000
IDR 100.000 Disc -90%
Kuantitas